Treatment Of Huvecs And Smcs With Rgd And Cxcl 1 Does Not Impair Cell

Treatment of HUVECs and SMCs with RGD and CXCL-1 does not impair cell ...
Treatment of HUVECs and SMCs with RGD and CXCL-1 does not impair cell ...
Treatment of HUVECs and SMCs with RGD and CXCL-1 does not impair cell ...
Treatment of HUVECs and SMCs with RGD and CXCL-1 does not impair cell ...
Cell viability test of SMCs and HUVECs (A) monoculture of SMCs; (B ...
Cell viability test of SMCs and HUVECs (A) monoculture of SMCs; (B ...
Cell viability of A) HUVECs and B) SMCs on SS substrates at days 1, 3 ...
Cell viability of A) HUVECs and B) SMCs on SS substrates at days 1, 3 ...
a) CMFDA (green) staining of HUVECs and CFDA (red) staining of SMCs on ...
a) CMFDA (green) staining of HUVECs and CFDA (red) staining of SMCs on ...
Cell adhesion capacity and cell morphology. (A) DAPI staining of HUVECs ...
Cell adhesion capacity and cell morphology. (A) DAPI staining of HUVECs ...
Cell viability of the co-culture of SMCs (A) and HUVEC (B) in mediums ...
Cell viability of the co-culture of SMCs (A) and HUVEC (B) in mediums ...
Culture of HUVECs after 5 days on RGD modified alginate (A) and ...
Culture of HUVECs after 5 days on RGD modified alginate (A) and ...
Bright field microscopy of HUVECs with vacuolin-1 and DMSO treatments ...
Bright field microscopy of HUVECs with vacuolin-1 and DMSO treatments ...
Generation of HUVECs with stable suppression of gene expression and ...
Generation of HUVECs with stable suppression of gene expression and ...
The Live/Dead staining of HUVECs and the cell proliferative activity ...
The Live/Dead staining of HUVECs and the cell proliferative activity ...
HUVECs express the transmembrane chemokine CX3CL1 but not CXCL16, and ...
HUVECs express the transmembrane chemokine CX3CL1 but not CXCL16, and ...
The distribution and biological characterization of GFP-HUVECs and SMCs ...
The distribution and biological characterization of GFP-HUVECs and SMCs ...
Treatment of HUVECs with blood serum exosomes. (A) HUVECs were ...
Treatment of HUVECs with blood serum exosomes. (A) HUVECs were ...
A. Western blotting of HUVECs treated or not treated with 0.1 to 1.0 ...
A. Western blotting of HUVECs treated or not treated with 0.1 to 1.0 ...
In vitro HUVECs behaviors and co‐culture of HUVECs/HASMCs (human ...
In vitro HUVECs behaviors and co‐culture of HUVECs/HASMCs (human ...
Cell death attributed to PA exposure in HUVECs and RCCECs. The cells ...
Cell death attributed to PA exposure in HUVECs and RCCECs. The cells ...
Effect of previous treatment of HUVECs with cytochalasin D in both ...
Effect of previous treatment of HUVECs with cytochalasin D in both ...
(a) HUVECs and (b) human coronary artery SMCs proliferation on various ...
(a) HUVECs and (b) human coronary artery SMCs proliferation on various ...
Methods of treatment and the mechanisms through which they function ...
Methods of treatment and the mechanisms through which they function ...
Effects of IL-1β in HUVECs on CXCL9 mRNA and CXCL9 ligand secretion. a ...
Effects of IL-1β in HUVECs on CXCL9 mRNA and CXCL9 ligand secretion. a ...
Effects of miR-214 OE -Exo on HUVECs and NRCMs. (A, D) Migration of ...
Effects of miR-214 OE -Exo on HUVECs and NRCMs. (A, D) Migration of ...
Histopathologic observation of HUVECs upon treatment with sclerosing ...
Histopathologic observation of HUVECs upon treatment with sclerosing ...
Morphology of HUVECs and HUSMCs on PCULx‐PO‐500 films (with 76 ng/cm² ...
Morphology of HUVECs and HUSMCs on PCULx‐PO‐500 films (with 76 ng/cm² ...
Serum‐free NBA AVM‐CM supported proliferation of HUVECs and SMCs, and ...
Serum‐free NBA AVM‐CM supported proliferation of HUVECs and SMCs, and ...
Comparison of Tube Formation of HUVECs Following Treatment with AG ...
Comparison of Tube Formation of HUVECs Following Treatment with AG ...
Treatment of HUVECs with blood serum exosomes. (A) HUVECs were ...
Treatment of HUVECs with blood serum exosomes. (A) HUVECs were ...
DANCR concerns melanoma cell promoting angiogenesis. A and B. HUVECs ...
DANCR concerns melanoma cell promoting angiogenesis. A and B. HUVECs ...
Paracrine effects of lineage-specific SMCs on HUVEC networks. HUVECs ...
Paracrine effects of lineage-specific SMCs on HUVEC networks. HUVECs ...
Azilsartan prevented ox-LDL-induced expressions of MCP-1 and CXCL1 in ...
Azilsartan prevented ox-LDL-induced expressions of MCP-1 and CXCL1 in ...
(A) Measurements of IL-1⍺, IL-1RA, CXCL-1/2, and hBD-1 on non-lesional ...
(A) Measurements of IL-1⍺, IL-1RA, CXCL-1/2, and hBD-1 on non-lesional ...
Effects of GDF11 on cell viability of HUVECs in serum-deprivation ...
Effects of GDF11 on cell viability of HUVECs in serum-deprivation ...
Figure S1 TGF- β 1 treatment (10 ng/ml) triggers SMCs differentiation ...
Figure S1 TGF- β 1 treatment (10 ng/ml) triggers SMCs differentiation ...
Reducing SGEF expression in HUVECs blocked RhoG activation and TEM. (A ...
Reducing SGEF expression in HUVECs blocked RhoG activation and TEM. (A ...
A–B) HUVECs were dispensed in a 96 well plate (3000 cells/well) and ...
A–B) HUVECs were dispensed in a 96 well plate (3000 cells/well) and ...
Cell cycle of HUVECs after 24 h of treatment, as detected by flow ...
Cell cycle of HUVECs after 24 h of treatment, as detected by flow ...

Loading image details...

Source
Dimensions